Learn More
The incompatibility reactions of four new R factors have been determined against reference plasmids of the compatibility groups FI, FII, FIII, FIV, FV, FVI and various not F-like groups. Two R factors have been found to belong to group FII, while one of the two other plasmids was incompatible with representatives of the FII and FI groups. The last R factor(More)
A number of transition metal complexes, including the cis and trans isomers of dichlorodiammineplatinum (II), six complexes of rhodium (I), two of iridium (I), and one of ruthenium (II) have been tested for their ability to induce lambda prophage, to produce filamentous growth of Escherichia coli, and to be selectively toxic for strains with defects in the(More)
pKM101, a plasmid R factor of the N compatibility group increases methylmethane sulfonate mutagenesis and diminishes UV-killing in recA + lex + and recA + lex − strains, but not in recA − lex + strains. The induction of a “reclex” dependent colicin is not present in lex − strains carrying the pKM101 factor. These facts indicate that pKM101 acts through an(More)
pTM89, an fi+ R factor that controls the production of repressed F-type pili, is incompatible with plasmids belonging to the FII and P groups. The results of P1 transduction show that all of the resistance markers of pTM89 are part of a single replicon, which also includes RTF. When the compatibility of different derivative plasmids was investigated, it was(More)
Eighteen patients of either sex (14 M; 4 F), ranging in age from 23 to 79 years, with clinical diagnosis of complicated cystitis due to Rufloxacin sensitive pathogens, were enrolled. Rufloxacin was administered orally at the dosage of 400 mg/die the first day; 200 mg/die the following 6 days or more. The mean duration of treatment was 7.25 +/- 0.78 days. No(More)
  • 1